18
Participants
Start Date
December 23, 2020
Primary Completion Date
February 24, 2022
Study Completion Date
August 1, 2022
FIASP + closed loop device
Participants will be advised to change their usual insulin to the corresponding study visit insulin formulation, 24 hours prior to admission. (For example; if the participant is on insulin aspart, this will be changed to faster-acting aspart 24-hour prior to the admission for closed loop with faster-acting aspart and vice versa).
Insulin aspart (standard of care insulin) + closed loop device
Participants will be advised to maintain their usual insulin 24 hours prior to admission.
Manchester University Hospitals NHS Foundation Trust, Manchester
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Manchester University NHS Foundation Trust
OTHER_GOV